COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults

Ann Intern Med. 2021 Apr;174(4):572-576. doi: 10.7326/M20-4986. Epub 2020 Oct 21.

Authors

Ashley Kieran Clift¹, Carol A C Coupland², Ruth H Keogh³, Harry Hemingway⁴, Julia Hippisley-Cox¹

Affiliations

¹ University of Oxford, Oxford, United Kingdom.
² University of Nottingham, Nottingham, United Kingdom.
³ London School of Hygiene & Tropical Medicine, London, United Kingdom.
⁴ University College London, Health Data Research UK, and National Institute for Health Research Biomedical Research Centre, London, United Kingdom.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
COVID-19 / mortality*
Down Syndrome / complications*
Female
Humans
Male
Middle Aged
Risk Factors
SARS-CoV-2
United Kingdom / epidemiology

Grants and funding